INIS
insulin
100%
levels
53%
ovaries
53%
glucose
38%
hormones
30%
women
30%
sensitivity
23%
doses
23%
globulins
23%
tolerance
15%
testosterone
15%
dehydroepiandrosterone
15%
sulfates
15%
estrone
15%
therapy
7%
comparative evaluations
7%
control
7%
hypothesis
7%
pathogenesis
7%
secretion
7%
fasting
7%
weight
7%
sex
7%
estradiol
7%
androstenedione
7%
regression analysis
7%
augmentation
7%
nitrogen 10
7%
Medicine and Dentistry
Polycystic Ovary Syndrome
53%
Troglitazone
53%
Insulin Sensitivity
23%
Insulin Sensitizing Agent
23%
Glucose
15%
Testosterone
15%
Insulin Resistance
15%
Prasterone Sulfate
15%
Estrone
15%
Insulin Response
15%
Hormone Binding Protein
15%
Lead
15%
Pathogenesis
7%
Regression Analysis
7%
Combination Therapy
7%
Group Therapy
7%
Glucose Tolerance
7%
Insulin Release
7%
Androstenedione
7%
Estradiol
7%
Glucose Test
7%
Sex Hormone Binding Globulin
7%
Luteinizing Hormone Release
7%
Hyperinsulinemia
7%
Intravenous Glucose Tolerance Test
7%
Menstruation
7%
Steroidogenesis
7%
Luteinizing Hormone
7%
Age
7%
Therapeutic Procedure
7%
Amaurosis
7%
Biochemistry, Genetics and Molecular Biology
Troglitazone
53%
Glucose
30%
Insulin
30%
Insulin Sensitivity
23%
Dose
23%
Globulin
15%
Insulin Resistance
15%
Testosterone
15%
Hormone Binding
15%
Insulin Response
15%
Insulin Level
15%
Dehydroepiandrosterone Sulfate
15%
Estradiol
7%
Luteinizing Hormone Release
7%
Body Mass
7%
Steroid Biosynthesis
7%
Menstruation
7%
Age
7%
Insulin Release
7%
Glucose Tolerance Test
7%
Weight
7%
Sex Hormone-Binding Globulin
7%
Nursing and Health Professions
Troglitazone
53%
Insulin Sensitizing Agent
23%
Prasterone Sulfate
15%
Hormone Binding Protein
15%
Intravenous Glucose Tolerance Test
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hormone Binding Protein
15%